Ghassan K. Abou‐Alfa
Author
Alternate names G. Abou‐Alfa, Ghassan K. Abou‐Alfa, Ghassan Khaled Abou‐Alfa, Ghassan Abou‐Alfa, G. K. Abou‐Alfa
Institutions Memorial Sloan Kettering Cancer Center, Cornell University, Cornell College, Trinity College Dublin
Past institutions Memorial Sloan Kettering Cancer Center, Cornell University, Trinity College Dublin, Trinity College, Cornell College +5 more
ORCID: Yes
H-index: 69
I10-index: 215
Works count: 721
Citations count: 23,940
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
2018 · Ghassan K. Abou‐Alfa, Tim Meyer, et al. · New England Journal of Medicine
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 · Ghassan K. Abou‐Alfa, Vaibhav Sahai, et al. · The Lancet Oncology
Phase II Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma
2006 · Ghassan K. Abou‐Alfa, Lawrence H. Schwartz, et al. · Journal of Clinical Oncology